CENTER ID: | AcbaC.17867.a |
ORGANISM: | Acinetobacter baumannii AB5075-UW |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
unclassified |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
AcbaC.17867.a.B1.GE38762 | full length | 1 | 310 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
AcbaC.17867.a.B1.PS02439 | full length | 1 | 310 | ||
AcbaC.17867.a.B1.PS38105 | full length | 1 | 310 |
RESOURCE | REFERENCE ID |
---|---|
BV-BRC: | fig|470.1345.peg.923 |
GenBank: | AKA30713.1 |
PGAT: | acinetobacter:ABUW_0959 |
RefSeq: | WP_000025988.1 |
UniProt: | X2KZW3 |
HARVESTED ON: | 1/22/2015 |
SEQUENCED ON: | 1/15/2015 |
EXPECTED MW: | 33kDa |
OBSERVED MW: | 33kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Too many to count (100+) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 6/2/2015 |
CONCENTRATION: | 46.4mg/ml |
OBSERVED MW: | 34kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | 20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 3 |
VIAL VOLUME: | 110µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 11/3/2016 |
CONCENTRATION: | 13.51mg/ml |
OBSERVED MW: | 34kDa |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | SEC |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 6 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |